Search
Spotlight
In-person and virtual events just for HCPs
In-person and virtual events just for HCPs
Specialty
View More
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
News
OncClub
All Oncology News
OncClub
All Oncology News
Media
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Conferences
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Partners
Publications
Resources
Interactive Tools
Sponsored
Interactive Tools
Sponsored
Biomarker Consortium
Subscribe
Search
Spotlight
In-person and virtual events just for HCPs
Specialty
See All >
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Immuno-Oncology | Specialty
home
Content Type
Future Immunotherapy Strategies in Cancer
July 18th 2014
Checkpoint Inhibitors Under Exploration in RCC
July 18th 2014
Return of Interferon in RCC
July 18th 2014
Potential Immunotherapy Combinations in RCC
July 18th 2014
PD-1 Combinations Explored in RCC
July 18th 2014
Immunotherapy Combination Strategies in RCC
July 18th 2014
Sequencing Checkpoint Inhibitors in NSCLC
July 18th 2014
Optimizing Checkpoint Inhibition in NSCLC
July 18th 2014
Immune Checkpoint Inhibitors in NSCLC
July 18th 2014
Evolving Renal Cell Carcinoma Treatment Paradigm
July 18th 2014
Rini Explores PD-1 Inhibition in Renal Cell Carcinoma
July 18th 2014
Development of Checkpoint Inhibitors for GU Cancers
July 18th 2014
Checkpoint Inhibition in Renal Cell Carcinoma
July 18th 2014
Utility of PD-L1 as a Biomarker in Bladder Cancer
July 18th 2014
Evolving Role of PD-L1 as a Biomarker
July 18th 2014
PD-L1 Immunotherapy in Bladder Cancer
July 18th 2014
Targeted Immunotherapy in Cancer
July 18th 2014
Future Role of Immunotherapy in Cancer
July 18th 2014
PD-L1 Inhibition With MPDL3280A in Bladder Cancer
July 18th 2014
Adjuvant Ipilimumab in High-Risk Melanoma
July 18th 2014
NEXT PAGE
<
1
...
177
178
179
180
181
182
183
184
185
...
194
>
PREVIOUS PAGE